These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 30720161)
1. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2. Fan H; Zhang YS Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161 [TBL] [Abstract][Full Text] [Related]
2. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4. Hu CY; You P; Zhang J; Zhang H; Jiang N Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis. Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation. Mao G; Zhang Z; Huang Z; Chen W; Huang G; Meng F; Zhang Z; Kang Y Osteoarthritis Cartilage; 2017 Apr; 25(4):521-532. PubMed ID: 27884646 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma. Ma F; Huang J; Li W; Li P; Liu M; Xue H Environ Toxicol; 2022 Jul; 37(7):1675-1685. PubMed ID: 35286011 [TBL] [Abstract][Full Text] [Related]
6. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828 [TBL] [Abstract][Full Text] [Related]
7. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis. Dai W; Dai JL; Tang MH; Ye MS; Fang S World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472 [TBL] [Abstract][Full Text] [Related]
8. MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3. Xu LZ; Ning JZ; Ruan Y; Cheng F J Clin Lab Anal; 2022 Apr; 36(4):e24360. PubMed ID: 35303365 [TBL] [Abstract][Full Text] [Related]
9. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1. Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212 [TBL] [Abstract][Full Text] [Related]
10. TGF-β1-regulated miR-3691-3p targets Hu YM; Lou XL; Liu BZ; Sun L; Wan S; Wu L; Zhao X; Zhou Q; Sun MM; Tao K; Zhang YS; Wang SL Asian J Androl; 2021; 23(2):188-196. PubMed ID: 33159025 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030 [TBL] [Abstract][Full Text] [Related]
12. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells. Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749 [TBL] [Abstract][Full Text] [Related]
13. MiR-455-3p activates Nrf2/ARE signaling via HDAC2 and protects osteoblasts from oxidative stress. Zhang S; Wu W; Jiao G; Li C; Liu H Int J Biol Macromol; 2018 Feb; 107(Pt B):2094-2101. PubMed ID: 29042277 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of miR-489-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting Histone Deacetylase 2 (HDAC2). Jia T; Wang M; Yan W; Wu W; Shen R Neuroscience; 2022 Feb; 484():16-25. PubMed ID: 34914969 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer. Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848 [TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP. Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729 [TBL] [Abstract][Full Text] [Related]
17. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway. Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177 [No Abstract] [Full Text] [Related]
18. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment. Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181 [TBL] [Abstract][Full Text] [Related]
19. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation. Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]